Notable Call Buying Activity in Teva Pharma (TEVA) Continues -Susquehanna
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/21/2026
- Wall Street sinks as bond yields rise, Walmart results disappoint
- Walmart shares fall despite earnings beat
- Alibaba stock dips as Q2 profit misses estimates despite strong AI cloud growth
- Wolfe remains "broadly bullish on AI semis stocks", names Top Pick
- Moderna stock pulls back after massive one-day rally: analysts weigh in
- Wall Street sinks as bond yields rise, Walmart results disappoint
- Wolfe remains "broadly bullish on AI semis stocks", names Top Pick
- Supermicro probe finds no senior management link to export violations
- SpaceX shares fall as second lockup period ends
- Hertz Global amends voting agreement with CK Amarillo after lawsuit
'Bullish Options Flow' in Teva Pharma (TEVA) Continues -Susquehanna
December 1, 2017 2:42 PM ESTSusquehanna options strategist Alison Edwards notes continued bullish options flow in Teva Pharma (NYSE: TEVA), as investors sold 5k Dec 14 Calls at $1.83 closing to buy 7k Dec 15 Calls $for 1.10, opening. Trading makes investor long ~30k Dec 156 calls. Also today, investors bought 13k Jan 17.5... More
Teva Pharma (TEVA) PT Raised to $16 at Mizuho Securities on Announced Major Cost Cuts
November 29, 2017 6:45 AM ESTMizuho Securities raised its price target on Teva Pharma (NYSE: TEVA) to $16.00 (from $12.00) while maintaining a Neutral rating, following a model update fueled by conversations with management.
Analyst Irina Koffler notes a positive outlook on the shares, following conversations with management... More
Teva Pharma (TEVA) Announces New Organization Structure, Leadership Changes
November 27, 2017 9:03 AM ESTTeva Pharmaceutical Industries Ltd. (NYSE & TASE: TEVA) announced today a new organization and leadership structure aimed to achieve better commercial focus and drive value creation. The new structure will enable strategic alignment across the portfolio, across regions and between functions, leveraging scale, enhancing agility, extracting efficiencies and providing increased proximity to the markets. This new structure will be implemented effective immediately.
... More
Teva Pharma (TEVA) Says It Isn't Planning to Divest Oncology/Pain Assets, Reassessed Situation - Bloomberg
November 27, 2017 8:27 AM ESTTeva Pharma (NYSE: TEVA) Says It Isn't Planning to Divest Oncology/Pain Assets, Reassessed Situation - Bloomberg
... More